Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1108 of 6351
-
New chemo combo aims to help laryngeal cancer patients keep their voice
Disease control OngoingThis study compare the survival without laryngeal dysfunction 2 years after the end of treatment, obtained by chemotherapy followed by radiotherapy or chemotherapy with cisplatin administrated during radiotherapy.
Phase 3 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated Jun 26, 2026 12:59 UTC
-
Simple blood test could spot transplant rejection before damage is done
Knowledge-focused Recruiting nowStudy Description: Heart and lung transplants can save lives, but long-term success is often limited by organ rejection that is hard to detect early. This study is testing a new, non-invasive blood test that looks for small pieces of DNA from the donor organ in the patient s blo…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
New radiation approach may help rectal cancer patients avoid surgery
Disease control OngoingThe investigators propose to conduct a randomised study on cT2, cT3a-b tumours less than 5 cm using two different techniques of radiotherapy boost following neoadjuvant chemoradiotherapy (nCRT) (CAP45): EBRT (9 Gy/5 fractions) or CXB (90 Gy/3 fractions). The endpoint will be orga…
Phase 3 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
CT-Guided tuning: a new way to Fine-Tune cochlear implants?
Symptom relief By invitation onlyCochlear implants are surgically implanted devices which restore the ability to hear to the hearing impaired. While remarkably successful, even in the best of performers restoration of hearing to levels of normal listeners is unusual. Approximately 3 weeks after surgery, cochlear…
Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Could a simple antibiotic boost survival in severe alcoholic hepatitis?
Disease control CompletedTreatment of reference of severe alcoholic hepatitis is based on corticosteroids, given for 28 days. However, about 25-35% of patients do not take benefit from this treatment and die within the 6 months following the diagnosis. Numerous trials have evaluated the impact of several…
Phase 3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Immunotherapy shows promise in controlling advanced breast cancer after chemo
Disease control OngoingThis phase II trial studies how well pembrolizumab works in treating patients with stage IV inflammatory breast cancer or triple-negative breast cancer that has spread to other places in the body (metastatic) or has come back (recurrent), and who have achieved clinical response o…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New combo therapy shows promise for tough prostate cancer
Disease control CompletedThis study aims to determine the safety and tolerability of Radium-223 when administered in combination with enzalutamide in progressive metastatic castrate-resistant prostate cancer.
Phase 2 • Sponsor: Cancer Trials Ireland • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could an immune booster help kids fight deadly brain cancer?
Disease control OngoingThis phase I trial studies the side effects and best dose of pembrolizumab and to see how well it works in treating younger patients with high-grade gliomas (brain tumors that are generally expected to be fast growing and aggressive), diffuse intrinsic pontine gliomas (brain stem…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Promising combo therapy targets aggressive lymphoma in young patients
Disease control OngoingThis phase II trial studies how well ibrutinib, rituximab, and consolidation chemotherapy consisting of cyclophosphamide, vincristine sulfate, doxorubicin hydrochloride, dexamethasone, methotrexate, and cytarabine work in treating young patients with newly diagnosed mantle cell l…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Hand transplants from deceased donors offer new hope for amputees
Disease control CancelledThe purpose of this study is to see if an investigational surgery that transfers tissue from a non-living donor to living individual will help restore greater function, appearance, and sensation to the hand and forearm areas of individuals who have suffered traumatic injury to th…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a drug shorten dialysis for kids with a rare kidney disease?
Disease control CompletedThe investigators aim to perform the first controlled randomized prospective study using ECZ in pediatric STEC-HUS. This is of great interest as there is still no efficient specific therapy in that potentially devastating disease. Furthermore, published data concerning the use o…
Phase 3 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Hope for young cancer survivors: ovarian tissue freezing may preserve fertility
Disease control OngoingBackground: Due to the remarkable improvement in treatments these last decades, long term survival can be expected in more than 80% of childhood cancer patients. Unfortunately, cancer treatments can be harmful to the gonads and can affect reproductive and endocrine functions. Wh…
Sponsor: Gumy-Pause Fabienne • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
15-Minute MRI could spot hidden cancers in BRCA carriers
Diagnosis OngoingThe purpose of this study is to create a rapid scan of the pancreas and ovaries that could be used in the future to screen patients at risk for pancreatic or ovarian cancers. Currently, Magnetic Resonance Imaging (MRI) examinations of the pancreas and ovaries can last 30-45 minut…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
Chocolate pill and multivitamin put to the test against heart disease and cancer
Prevention CompletedThe purpose of this study is to determine whether taking daily, dietary supplements of cocoa extract (containing cocoa flavanols and theobromine from the cocoa bean) and/or a standard multivitamin reduces the risk of developing cardiovascular disease (including heart attack, stro…
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jul 15, 2026 00:00 UTC
-
Can a cheap clot drug save lives in blood cancer patients?
Disease control CompletedThe purpose of this study is to test whether giving tranexamic acid to patients receiving treatment for blood cancers reduces the risk of bleeding or death, and the need for platelet transfusions. Patients will be randomised to receive tranexamic acid (given intravenously through…
Phase 3 • Sponsor: NHS Blood and Transplant • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New antipsychotic ITI-007 put to the test in large schizophrenia trial
Disease control CompletedThe study will evaluate the antipsychotic efficacy of ITI-007 in a randomized, double-blind, parallel-group, placebo- and active-controlled, multi-center study in patients diagnosed with schizophrenia having an acute exacerbation of psychosis.
Phase 3 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden brain tumors
Disease control CompletedPrimary malignant and non-malignant brain tumors account for an estimated 21.42 cases per 100,000 for a total count of 343,175 incident tumors based on worldwide population estimates \[1\]. These entities result in variable but disappointing rates of survival, particularly for pr…
Phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New vaccine aims to train immune system against breast cancer stem cells
Vaccine OngoingThis phase I trial studies the side effects and best dose of multiantigen deoxyribonucleic acid (DNA) plasmid-based vaccine in treating patients with human epidermal growth factor receptor 2 (HER2)-negative stage III-IV breast cancer. Multiantigen DNA plasmid-based vaccine may ta…
Phase 1 • Sponsor: University of Washington • Aim: Vaccine
Last updated Jun 27, 2026 09:06 UTC
-
Promising combo aims to tame relapsed childhood cancers
Disease control OngoingThis study aims to determine the efficacy of daily sirolimus and celecoxib, with low dose etoposide alternating with cyclophosphamide for pediatric participants with relapsed or refractory tumors.
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New HIV prevention strategy shows promise for At-Risk men in africa
Prevention CompletedThe objective of the study is to evaluate the feasibility and interest of a HIV quarterly preventive global care for men who have sex with men (MSM) in sub-Saharan Africa to help reducing HIV incidence in this key population, their female partners, and the general population. Thi…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC